Skip to main content
. 2024 Apr 23;15:1388967. doi: 10.3389/fimmu.2024.1388967

Table 2.

Association between non-specific indictors of systemic inflammation and insulin resistance and fatty liver disease in psoriasis.

Exposures Model 1 a
Crude OR (95% CI)
Model 2 b
Adjusted OR (95% CI)
Model 3 c
Adjusted OR (95% CI)
NLR
Q1 Ref. Ref. Ref.
Q2 1.123 (0.775-1.627) 1.055 (0.705-1.579) 1.038 (0.690-1.562)
Q3 0.881 (0.607-1.279) 0.932 (0.620-1.401) 0.897 (0.591-1.360)
dNLR
Q1 Ref. Ref. Ref.
Q2 1.206 (0.832-1.750) 1.085 (0.726-1.622) 1.049 (0.697-1.576)
Q3 0.916 (0.631-1.329) 0.933 (0.623-1.399) 0.887 (0.586-1.343)
SII
Q1 Ref. Ref. Ref.
Q2 0.843 (0.581-1.222) 0.780 (0.521-1.165) 0.767 (0.510-1.150)
Q3 0.898 (0.620-1.301) 0.967 (0.646-1.446) 0.932 (0.618-1.405)
TyG
Q1 Ref. Ref. Ref.
Q2 1.756 (1.181-2.623) 1.817 (1.179-2.815) 1.871 (1.206-2.919)
Q3 3.131 (2.136-4.624) 2.621 (1.730-3.999) 2.704 (1.750-4.206)
TyG-BMI
Q1 Ref. Ref. Ref.
Q2 2.495 (1.666-3.769) 2.575 (1.710-3.913) 2.584 (1.708-3.944)
Q3 8.189 (5.400-12.603) 8.300 (5.438-12.860) 7.946 (5.138-12.480)

OR, odds ratio; CI, confidence interval; NLR, neutrophil-to-lymphocyte ratio; dNLR, derived neutrophil-to-lymphocyte ratio; SII, systemic immune inflammation index; TyG, triglyceride-glucose; TyG-BMI, triglyceride glucose-body mass index; Ref, reference.

a

No covariates analyzed.

b

Covariates analyzed adjusted for age, gender, smoking, drinking, and BMI.

c

All covariates analyzed.